Unknown

Dataset Information

0

Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.


ABSTRACT:

SUBMITTER: Crossingham I 

PROVIDER: S-EPMC8096360 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.

Crossingham Iain I   Turner Sally S   Ramakrishnan Sanjay S   Fries Anastasia A   Gowell Matthew M   Yasmin Farhat F   Richardson Rebekah R   Webb Philip P   O'Boyle Emily E   Hinks Timothy Sc TS  

The Cochrane database of systematic reviews 20210504


<h4>Background</h4>Asthma affects 350 million people worldwide including 45% to 70% with mild disease. Treatment is mainly with inhalers containing beta₂-agonists, typically taken as required to relieve bronchospasm, and inhaled corticosteroids (ICS) as regular preventive therapy. Poor adherence to regular therapy is common and increases the risk of exacerbations, morbidity and mortality. Fixed-dose combination inhalers containing both a steroid and a fast-acting beta₂-agonist (FABA) in the same  ...[more]

Similar Datasets

| S-EPMC8241158 | biostudies-literature
| S-EPMC5005184 | biostudies-literature
| S-EPMC3268716 | biostudies-literature
| S-EPMC5718039 | biostudies-literature
| S-EPMC6946676 | biostudies-literature
| S-EPMC3431221 | biostudies-literature
| S-EPMC4934872 | biostudies-literature
| S-EPMC9942181 | biostudies-literature
| S-EPMC4023854 | biostudies-literature
| S-EPMC7407001 | biostudies-literature